Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.04. | APPYEA, INC - 10-K, Annual Report | - | SEC Filings | ||
20.03. | APPYEA, Inc.: AppYea Launches E-Commerce Store on Amazon Broadening Distribution | 363 | ACCESSWIRE | AppySleep smart wristband now available on AmazonSuccessful ful?llment of all pre-ordersEntering the 17.9 Billion Sleep Tech Device MarketGAN YAVNE, ISRAEL / ACCESSWIRE / March 20, 2024 / AppYea, Inc.... ► Artikel lesen | |
10.01. | APPYEA, Inc.: AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S. | 401 | ACCESSWIRE | AppySleep now available for purchase onlinePlans to sell the product in stores as part of planned second phase of rolloutGAN YAVNE, ISRAEL / ACCESSWIRE / January 10, 2024 / AppYea, Inc. (OTCQB:APYP)... ► Artikel lesen | |
13.12.23 | APPYEA, Inc.: AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024 | 234 | ACCESSWIRE | GAN YAVNE, ISRAEL / ACCESSWIRE / December 13, 2023 / AppYea Inc. (OTCQB:APYP), focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today provided... ► Artikel lesen | |
16.11.23 | APPYEA, INC - 10-Q, Quarterly Report | 3 | SEC Filings | ||
13.11.23 | APPYEA, INC - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
28.08.23 | AppYea, Inc.: AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis | 434 | ACCESSWIRE | New Patent Promises Affordable and Convenient Sleep Apnea Diagnostics; Market Projected to Reach US$ 9.27 Billion by 2033GAN YAVNE, ISRAEL / ACCESSWIRE / August 28, 2023 / SleepX, a subsidiary of AppYea... ► Artikel lesen | |
03.08.23 | APPYEA, Inc.: AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch | 515 | ACCESSWIRE | Transaction expected to streamline capital structure and ultimately result in the elimination of all Company debtGAN YAVNE, ISRAEL / ACCESSWIRE / August 3, 2023 / AppYea Inc. (OTC:APYP), a healthtech... ► Artikel lesen | |
31.07.23 | APPYEA, Inc.: AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO | 382 | ACCESSWIRE | GAN YAVNE, ISRAEL / ACCESSWIRE / July 31, 2023 / AppYea Inc. (OTC:APYP), which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today announced... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS | 27,210 | +0,11 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | Fresenius Medical Care: Was war das denn gestern? | Mit einem Kursanstieg um satte 6,44 Prozent wurde Fresenius Medical Care am Montag klarer Tagessieger im MDAX. Aber was war da los, was trieb die Aktie so stark? Vorab-Ergebnisse zum ersten Quartal... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GERRESHEIMER | 100,50 | +1,31 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler: Kurssprung nach Vorab-Zahlen … was ist das wert? | Am Montagnachmittag wartete der Strahlentechnik-Spezialist Eckert & Ziegler mit vorläufigen Ergebnissen zum 1. Quartal auf. Die Aktie machte einen Satz nach oben ... wie lässt sich das charttechnisch... ► Artikel lesen | |
GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |